OCALA, Fla.--(BUSINESS WIRE)--AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the Company has filed its Definitive Proxy Statement in connection with AIM’s ...
SAN FRANCISCO (MarketWatch) -- AIM Investments of Houston, Texas, a unit of Anglo-American asset manager Amvescap PLC , has filed to launch six new mutual-funds. Each will be organized as a ...
16:37 EST AIM ImmunoTech (AIM) files to sell 9.31M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...
Thank you for your investment in AIM ImmunoTech (“AIM” or the “Company”). We remain deeply committed to our mission of serving patients and delivering value for you, our shareholders. We are excited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback